Researchers found the risk of heart attack or stroke in obese patients given a 2.4mg once-weekly dose of Wegovy, alongside standard care for the prevention of heart attacks or stroke, reduced by a fifth compared with those given a placebo drug
Context for confounding and differential diagnosis: SGLT2 inhibitors are known to increase genital mycotic infection risk, including vulvovaginal candidiasis, and real-world studies demonstrate clinically significant vaginitis incidence in usersmaking SGLT2 exposure a critical confounder when patients attribute yeast infections to semaglutide
1c) when compared to PBS control
Because sustainable weight loss builds over time
Were seeing this new patient population enter aesthetics with different concerns, different goals, and a strong desire for individualized, long-term treatment and care, particularly when it comes to restoring facial balance and volume. Company data shows that 67% of patients reported their goals shifted toward improving appearancenot just losing weightafter beginning medical weight loss treatment
This proved the normalization of postprandial hyperglycemia and reduction of serum glycated hemoglobin